81 related articles for article (PubMed ID: 25018881)
1. High-risk Human Papillomavirus Determination in Formalin-fixed, Paraffin-embedded Cervical Tissue Using the Roche Cobas 4800 System: A Comparative Study With Liquid-based Cytology.
Tardío JC; Cambero O; Sánchez-Estévez C; Sánchez-García AB; Angulo F; Moreno A
Int J Gynecol Pathol; 2019 Jan; 38(1):11-16. PubMed ID: 29140880
[TBL] [Abstract][Full Text] [Related]
2. E2/E6 ratio and L1 immunoreactivity as biomarkers to determine HPV16-positive high-grade squamous intraepithelial lesions (CIN2 and 3) and cervical squamous cell carcinoma.
Choi YJ; Lee A; Kim TJ; Jin HT; Seo YB; Park JS; Lee SJ
J Gynecol Oncol; 2018 May; 29(3):e38. PubMed ID: 29400024
[TBL] [Abstract][Full Text] [Related]
3. Altered Immunohistochemical Expression Patterns of HLA Class I during the Clinical Course of Cervical Intraepithelial Neoplasia.
Koguchi O; Nishimaki H; Nakanishi Y; Kobayashi H; Ohni S; Tang X; Kusumi Y; Masuda S
Acta Histochem Cytochem; 2021 Apr; 54(2):57-64. PubMed ID: 34012177
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Conservative Management of High Grade Squamous Intraepithelial Lesions in Young Women.
Lee MH; Finlayson SJ; Gukova K; Hanley G; Miller D; Sadownik LA
J Low Genit Tract Dis; 2018 Jul; 22(3):212-218. PubMed ID: 29762428
[TBL] [Abstract][Full Text] [Related]
5. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
[TBL] [Abstract][Full Text] [Related]
6. Genomic amplification of hTERC in paraffin-embedded tissues of cervical intraepithelial neoplasia and invasive cancer.
He C; Xu C; Xu M; Yuan Y; Sun Y; Zhao H; Zhang X
Int J Gynecol Pathol; 2012 May; 31(3):280-5. PubMed ID: 22498947
[TBL] [Abstract][Full Text] [Related]
7. Advances in Nanotechnology for Cancer Immunoprevention and Immunotherapy: A Review.
Koyande NP; Srivastava R; Padmakumar A; Rengan AK
Vaccines (Basel); 2022 Oct; 10(10):. PubMed ID: 36298592
[TBL] [Abstract][Full Text] [Related]
8. Prediction Models for Prognosis of Cervical Cancer: Systematic Review and Critical Appraisal.
He B; Chen W; Liu L; Hou Z; Zhu H; Cheng H; Zhang Y; Zhan S; Wang S
Front Public Health; 2021; 9():654454. PubMed ID: 34026714
[No Abstract] [Full Text] [Related]
9. Cancer Immunoprevention: Current Status and Future Directions.
Keshavarz-Fathi M; Rezaei N
Arch Immunol Ther Exp (Warsz); 2021 Feb; 69(1):3. PubMed ID: 33638703
[TBL] [Abstract][Full Text] [Related]
10. Vaginal Microbiome-Based Bacterial Signatures for Predicting the Severity of Cervical Intraepithelial Neoplasia.
Lee YH; Kang GU; Jeon SY; Tagele SB; Pham HQ; Kim MS; Ahmad S; Jung DR; Park YJ; Han HS; Shin JH; Chong GO
Diagnostics (Basel); 2020 Nov; 10(12):. PubMed ID: 33256024
[TBL] [Abstract][Full Text] [Related]
11. Personalized Human Papillomavirus Vaccination for Persistence of Immunity for Cervical Cancer Prevention: A Critical Review With Experts' Opinions.
Chambuso RS; Rebello G; Kaambo E
Front Oncol; 2020; 10():548. PubMed ID: 32391264
[TBL] [Abstract][Full Text] [Related]
12. Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology.
Gustavsson I; Aarnio R; Berggrund M; Hedlund-Lindberg J; Strand AS; Sanner K; Wikström I; Enroth S; Olovsson M; Gyllensten U
Br J Cancer; 2018 Mar; 118(6):896-904. PubMed ID: 29438367
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care test for cervical cancer in LMICs.
Mohammed SI; Ren W; Flowers L; Rajwa B; Chibwesha CJ; Parham GP; Irudayaraj JM
Oncotarget; 2016 Apr; 7(14):18787-97. PubMed ID: 26934314
[TBL] [Abstract][Full Text] [Related]
14. Physiological and pathophysiological roles for phospholipase D.
Nelson RK; Frohman MA
J Lipid Res; 2015 Dec; 56(12):2229-37. PubMed ID: 25926691
[TBL] [Abstract][Full Text] [Related]
15. Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis.
Uleberg KE; Ovestad IT; Munk AC; Brede C; van Diermen B; Gudlaugsson E; Janssen EA; Hjelle A; Baak JP
Int J Proteomics; 2014; 2014():129064. PubMed ID: 25018881
[TBL] [Abstract][Full Text] [Related]
16. Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies.
Uleberg KE; Munk AC; Brede C; Gudlaugsson E; van Diermen B; Skaland I; Malpica A; Janssen EA; Hjelle A; Baak JP
Proteome Sci; 2011 Jun; 9():36. PubMed ID: 21711556
[TBL] [Abstract][Full Text] [Related]
17. Analysis of factors affecting the prognosis of patients with cervical intraepithelial neoplasia 2.
Zhang X; Xu Y; Meng T; Shen D
Oncol Lett; 2020 Aug; 20(2):1810-1816. PubMed ID: 32724424
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
